The landscape of dementia analysis has progressed radically with the advent of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology decades ahead of signs emerge. Although these technological developments stand for amazing progress in knowledge neurodegenerative ailments, they